Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantation.

Scant knowledge exists concerning lineage-restricted mixed chimerism (mCh) after allogeneic peripheral blood stem cell transplantation (PSCT) in patients with chronic idiopathic myelofibrosis (CIMF). Following a sex-mismatched PSCT, a combined immunopheno- and genotyping by fluorescence in-situ hybridization (FISH) was performed on sequential bone marrow (BM) biopsies at standardized intervals. Results were compared with PCR analysis of corresponding peripheral blood samples in five patients. According to FISH, pretransplant specimens revealed a gender congruence of more than 99%, while in the first three months the total BM exhibited a persistent fraction of host cells (30% to 40%) with a tendency to decline after about one year. It is noteworthy that the majority of endothelial cells maintained a recipient origin, whereas CD34+ progenitors and especially CD61+ megakaryocytes exhibited only very few host-derived cells. In keeping with the prevalence of donor cells in the hematopoietic compartment, PCR analysis of peripheral blood cells displayed a non-significant degree of mCh. In conclusion, according to FISH and PCR analysis, successful PSCT in CIMF results in an almost complete chimeric (donor-derived) state of the hematopoietic cell population. The non-transplantable stromal compartment includes the vascular endothelium with a predominance of recipient cells. The minimal mCh of this population implies probably a donor-derived origin (endothelial progenitor cells).

[1]  B. Andersson,et al.  Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis. , 2009 .

[2]  S. Chiba,et al.  Hematopoietic Stem Cell , 2020, Definitions.

[3]  H. Deeg,et al.  Hematopoietic stem cell transplantation for myelofibrosis. , 2005, Seminars in oncology.

[4]  R. Hoffman,et al.  Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia. , 2005, Blood.

[5]  J. Panse,et al.  Pilot study of reduced‐intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis , 2005, British journal of haematology.

[6]  T. Asahara,et al.  Endothelial progenitor cells for vasculogenesis. , 2005, Physiology.

[7]  H. Masuda,et al.  Endothelial progenitor cells: past, state of the art, and future , 2004, Journal of cellular and molecular medicine.

[8]  M. Hristov,et al.  Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance , 2004, Journal of cellular and molecular medicine.

[9]  J. Thiele,et al.  Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders. , 2004, Histology and histopathology.

[10]  G. Ehninger,et al.  Strategies and Clinical Implications of Chimerism Diagnostics after Allogeneic Hematopoietic Stem Cell Transplantation , 2004, Acta Haematologica.

[11]  G. Schatteman.  Adult bone marrow-derived hemangioblasts, endothelial cell progenitors, and EPCs. , 2004, Current topics in developmental biology.

[12]  C. Wickenhauser,et al.  Mixed Chimerism of Bone Marrow Vessels (Endothelial Cells, Myofibroblasts) Following Allogeneic Transplantation for Chronic Myelogenous Leukemia , 2003, Leukemia & lymphoma.

[13]  M. Bernard,et al.  Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. , 2002, Blood.

[14]  N. Kröger,et al.  Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation. , 2001, Journal of hematotherapy & stem cell research.

[15]  A. Elmaagacli,et al.  A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase , 2001, Bone Marrow Transplantation.

[16]  A. Kitzis,et al.  Persistence of Transcriptionally Silent BCR-ABL Rearrangements in Chronic Myeloid Leukemia Patients in Sustained Complete Cytogenetic Remission , 2001, Leukemia & lymphoma.

[17]  J. Furuyama,et al.  Early detection of relapse and evaluation of treatment for mixed chimerism using fluorescence in situ hybridization following allogeneic hematopoietic cell transplant for hematological malignancies , 2000, Annals of Hematology.

[18]  S. Dirnhofer,et al.  Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells , 2000, The Lancet.

[19]  A. Kitzis,et al.  Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation. , 2000, Blood.

[20]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells. , 1999, Blood.

[21]  C. Eaves,et al.  Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. , 1999, Blood.

[22]  M. Florek,et al.  Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection , 1999, Bone Marrow Transplantation.

[23]  S. Rafii,et al.  Regulation of Transendothelial Migration of Hematopoietic Progenitor Cells , 1999, Annals of the New York Academy of Sciences.

[24]  P. Harnden,et al.  Efficient nuclear FISH on paraffin-embedded tissue sections using microwave pretreatment. , 1999, BioTechniques.

[25]  A. Smith,et al.  Application of interphase FISH on direct bone marrow smears for evidence of chimerism in pediatric sex mismatched bone marrow transplantation. , 1999, Pathology.

[26]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[27]  M. Kennedy,et al.  A common precursor for hematopoietic and endothelial cells. , 1998, Development.

[28]  M. Talpaz,et al.  Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferon , 1998, Leukemia.

[29]  R. Scheuermann,et al.  Cancer dormancy: Opportunities for new therapeutic approaches , 1997, Nature Medicine.

[30]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[31]  M. Andreeff,et al.  Analysis of chimerism following allogeneic bone marrow transplantation by fluorescent-in-situ hybridization. , 1997, Leukemia & lymphoma.

[32]  S. Rafii,et al.  Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. , 1995, Blood.

[33]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[34]  D. H. Robinson,et al.  Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors. , 1995, Blood.

[35]  P. Wernet,et al.  Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells. , 1995, Bone marrow transplantation.

[36]  L. Barnett,et al.  Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. , 1994, Blood.

[37]  A. D. White,et al.  Detection of male cells in mixtures containing varying proportions of male and female cells by fluorescence in situ hybridization and G-banding. , 1993, Cytometry.

[38]  S. Pileri,et al.  Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia. , 1992, Bone marrow transplantation.

[39]  B. Longenecker,et al.  Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. , 1992, Blood.

[40]  J. Thiele,et al.  Vascular architecture and collagen type IV in primary myelofibrosis and polycythaemia vera: an immunomorphometric study on trephine biopsies of the bone marrow , 1992, British journal of haematology.

[41]  G. Cattoretti,et al.  Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. , 1991, Leukemia.

[42]  K. Agematsu,et al.  Recipient origin of bone marrow‐derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans , 1991, British journal of haematology.

[43]  H. Prentice,et al.  Origin of marrow stromal cells and haemopoietic chimaerism following bone marrow transplantation determined by in situ hybridisation. , 1990, British Journal of Cancer.

[44]  D. Mason,et al.  The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens , 1988, Histopathology.

[45]  H. Kantarjian,et al.  Lack of breakpoint cluster region rearrangement in marrow fibroblasts of patients with Philadelphia chromosome-positive chronic myelogenous leukemia. , 1988, Hematologic pathology.

[46]  P. Simmons,et al.  Host origin of marrow stromal cells following allogeneic bone marrow transplantation , 1987, Nature.

[47]  J. Reilly,et al.  Endothelial cell proliferation in myelofibrosis , 1985, British journal of haematology.

[48]  H Stein,et al.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[49]  R. Sparkes,et al.  Origin of Human Bone Marrow Fibroblasts , 1980, British journal of haematology.

[50]  B. Greenberg,et al.  Cytogentics of fibroblastic colonies in Ph1-positive chronic myelogenous leukemia. , 1978, Blood.

[51]  P. Endes,et al.  Chronic idiopathic myelofibrosis. A reversible disease?. , 1977, Acta haematologica.